Squire Patton Boggs

Firm overview:

Squire Patton Boggs has cultivated deep, long-standing client relationships, a reflection of its reputation for delivering high-quality patent services. The firm offers the full spectrum of domestic and international patent work, from drafting and prosecuting applications to developing and managing comprehensive global portfolios. Its attorneys serve clients across diverse industries, including life sciences, technology, consumer products, and industrial sectors.

In addition to prosecution, the firm has built a strong reputation in patent litigation and post-grant proceedings. Its teams combine technical expertise with strategic insight, helping clients navigate high-stakes disputes against larger IP practices, defend patent validity, and enforce rights in both administrative and courtroom settings. Life sciences companies, in particular, rely on the firm for its ability to quickly understand complex products, regulatory environments, and business priorities, especially in litigation against generic manufacturers.

Offices in the US, Europe, Asia and the Middle East collaborate to ensure clients’ patent strategies are aligned internationally, providing seamless guidance from early filings to commercialisation, licensing, and dispute resolution. The firm also continues to maintain thought leadership in IP through publications, events, and webinars, helping clients stay informed about evolving patent landscapes, emerging technologies, and regulatory changes. This combination of technical depth, strategic insight, and global coordination positions Squire Patton Boggs as a trusted partner for businesses seeking to protect, leverage, and enforce their IP.

Team overview:

David Elkins, partner and head of the global Intellectual Property & Technology Practice Group, remains a central figure in the firm’s patent practice. He serves as lead trial and arbitration counsel in complex patent disputes, while also advising clients on portfolio strategy, licensing, and global IP management. Elkins combines technical expertise with commercial insight, supporting life sciences, technology, and industrial clients in high-stakes litigation and strategic patent counselling.

Soumitra (Sam) Deka joined the San Francisco office in 2025 from DLA Piper, adding to the firm’s patent litigation capabilities. He focuses exclusively on patent disputes, including infringement, validity challenges, and arbitration, in US courts and international forums. Deka’s 20+ years of experience in complex patent litigation make him a key resource for clients facing high-value or technologically sophisticated patent cases.

Tamara Fraizer leads the US IP & Technology litigation practice, specialising in patent enforcement and defence for life sciences and technology clients. With a strong technical background and PhD in biology, Fraizer handles high-stakes patent litigation in federal courts and before the US International Trade Commission. She has successfully represented clients in complex patent disputes and post-grant proceedings, establishing a strong reputation in patent trial practice.

Key matters:

• Portfolio work for BioElectron Technology

The team advised patent prosecution client BioElectron Technology on its acquisition by PTC Therapeutics in 2019 for $210 million, and now represents PTC Therapeutics on the portfolio. This includes developing an IP portfolio around therapeutics for treating and preventing mitochondrial disorders and diseases.

• Portfolio work for Biogen

Squire Patton Boggs advises Biogen on the worldwide patent portfolio for multi-million dollar antibody therapeutic Tysabri (natalizumab).

• Sakata Seed America v Mitsuo Seed and Priority Seed.

The firm represents Sakata Seed, which has filed a patent suit against Mitsuo Seed and Priority Seed alleging infringement of a patent related to an inbred broccoli line and the use of it in creating hybrids.

Clients:

Biogen, Bridgestone Americas Tire Operations, DGL Group, Eaton Corporation, SunFlora, PTC Therapeutics, QuantumScape Battery, Quest USA, Sakata Seed America, University of California Davis.